Abstract
Des- gamma- carboxy prothrombin(DCP) ,as well as alpha-fetoprotein(AFP) ,has been considered as a useful serological tumor marker for hepatocellular carcinoma(HCC). As a clinical tumor marker of HCC, DCP has been accepted and widely used in clinic for many years. DCP and AFP have no significant correlation, and are complementary in the diagnosis of HCC. Combined detection of these two serological tumor markers in high-risk patients helps to the diagnosis of HCC in early stage. Moreover, these tumor markers can be used in the evaluation of therapy efficacy and prognosis. Key words: Prothrombin; Carcinoma,hepatocellular; Diagnosis; Prognosis
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
